Rekah Pharmaceutical Industry Ltd (REKA) — Tangible Net Worth Ratio
Rekah Pharmaceutical Industry Ltd (REKA) has a Tangible Net Worth Ratio of 61.0% as of December 2025. This metric is calculated by deducting intangible assets (ILA56.27 Million) from net assets (ILA144.21 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Rekah Pharmaceutical Industry Ltd (REKA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Rekah Pharmaceutical Industry Ltd Tangible Net Worth Ratio (2004–2025)
This chart shows how Rekah Pharmaceutical Industry Ltd's Tangible Net Worth Ratio has changed across 22 annual periods from 2004 to 2025. As of December 2025, the ratio stands at 61.0%, reflecting net assets of ILA144.21 Million with intangible assets of ILA56.27 Million ILA. See REKA defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd (2004–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Rekah Pharmaceutical Industry Ltd from 2004 to 2025, covering 22 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Rekah Pharmaceutical Industry Ltd (REKA) total market value.
| Year | Tangible NW Ratio | Net Assets (ILA) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 61.0% | ILA144.21 Million | ILA56.27 Million | ILA423.68 Million | ▼ -1.5 pp |
| 2024 | 62.4% | ILA161.98 Million | ILA60.84 Million | ILA447.22 Million | ▼ -17.2 pp |
| 2023 | 79.6% | ILA155.59 Million | ILA31.66 Million | ILA484.72 Million | ▼ -7.6 pp |
| 2022 | 87.2% | ILA162.08 Million | ILA20.67 Million | ILA448.42 Million | ▲ +6.3 pp |
| 2021 | 81.0% | ILA173.06 Million | ILA32.97 Million | ILA437.09 Million | ▼ -16.5 pp |
| 2020 | 97.5% | ILA165.59 Million | ILA4.18 Million | ILA419.69 Million | ▼ -1.0 pp |
| 2019 | 98.4% | ILA155.22 Million | ILA2.44 Million | ILA367.11 Million | ▼ -0.1 pp |
| 2018 | 98.5% | ILA150.66 Million | ILA2.21 Million | ILA300.28 Million | ▲ +0.1 pp |
| 2017 | 98.4% | ILA144.62 Million | ILA2.33 Million | ILA294.95 Million | ▼ -0.4 pp |
| 2016 | 98.8% | ILA105.86 Million | ILA1.26 Million | ILA322.72 Million | ▼ -0.3 pp |
| 2015 | 99.2% | ILA123.66 Million | ILA1.04 Million | ILA323.82 Million | ▲ +0.9 pp |
| 2014 | 98.2% | ILA77.06 Million | ILA1.37 Million | ILA310.11 Million | ▲ +1.5 pp |
| 2013 | 96.7% | ILA79.51 Million | ILA2.61 Million | ILA303.16 Million | ▲ +0.5 pp |
| 2012 | 96.2% | ILA71.17 Million | ILA2.71 Million | ILA298.07 Million | ▲ +1.0 pp |
| 2011 | 95.2% | ILA64.00 Million | ILA3.08 Million | ILA286.99 Million | ▲ +0.7 pp |
| 2010 | 94.5% | ILA63.78 Million | ILA3.51 Million | ILA287.97 Million | ▲ +1.0 pp |
| 2009 | 93.5% | ILA64.15 Million | ILA4.17 Million | ILA278.40 Million | ▲ +1.6 pp |
| 2008 | 91.9% | ILA58.62 Million | ILA4.72 Million | ILA290.50 Million | ▼ -2.3 pp |
| 2007 | 94.2% | ILA67.10 Million | ILA3.89 Million | ILA300.96 Million | ▼ -0.4 pp |
| 2006 | 94.6% | ILA61.54 Million | ILA3.35 Million | ILA296.53 Million | ▼ -1.7 pp |
| 2005 | 96.2% | ILA58.85 Million | ILA2.22 Million | ILA267.00 Million | ▲ +3.0 pp |
| 2004 | 93.2% | ILA48.86 Million | ILA3.30 Million | ILA202.04 Million | — |